INmune Bio prices $4.5 million offering, confirms Feb 2027 UK filing for RDEB therapy
Pricing of 3 million shares at $1.50 was announced October 28, 2026, a day after the company signed the purchase agreement, with closing expected October 29.
SEC filing (2)